FDA Inspection 1162948 — CHI Health CUMC - Bergan Mercy
The FDA completed an inspection of CHI Health CUMC - Bergan Mercy on February 17, 2022 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 17, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Omaha, NE (United States)